Background There is no proven specific pharmacological treatment for patients with the
acute respiratory distress syndrome (ARDS). The efficacy of corticosteroids in ARDS …

Objectives A recent update of the definition of acute respiratory distress syndrome (ARDS)
proposed an empirical classification based on ratio of arterial partial pressure of oxygen to …

Objectives: The driving pressure (plateau pressure minus positive end-expiratory pressure)
has been suggested as the major determinant for the beneficial effects of lung-protective …

Purpose We hypothesized that neurally adjusted ventilatory assist (NAVA) compared to
conventional lung-protective mechanical ventilation (MV) decreases duration of MV and …

Sepsis is a common cause of acute respiratory distress syndrome (ARDS) associated with a
high mortality. A panel of biomarkers (BMs) to identify septic patients at risk for developing …

Acute respiratory distress syndrome (ARDS) is an inflammatory process of the lungs that
develops primarily in response to pulmonary or systemic sepsis, resulting in a …

Introduction: In patients with acute respiratory distress syndrome (ARDS), the PaO2/FiO2
ratio at the time of ARDS diagnosis is weakly associated with mortality. We hypothesized …

Objectives: Incomplete or ambiguous evidence for identifying high-risk patients with acute
respiratory distress syndrome for enrollment into randomized controlled trials has come at …

Background: The ability to predict a long duration of mechanical ventilation (MV) by
clinicians is very limited. We assessed the value of machine learning (ML) for early …

Background The acute respiratory distress syndrome (ARDS) is one of the main causes of
mortality in adults admitted to intensive care units. Previous studies have demonstrated the …